The following pages link to H. M. James Hung (Q3076077):
Displayed 17 items.
- Challenges to multiple testing in clinical trials (Q3076078) (← links)
- Impacts on type I error rate with inappropriate use of learn and confirm in confirmatory adaptive design trials (Q3076083) (← links)
- Efficacy Evaluation for Monotherapies in Two-by-Two Factorial Trials (Q4335648) (← links)
- Large Sample Tests for Binary Outcomes in Fixed-Dose Combination Drug Studies (Q4349962) (← links)
- The Behavior of the P-Value When the Alternative Hypothesis is True (Q4349996) (← links)
- Use of Two-Stage Test Statistic in the Two-Period Crossover Trials (Q4360518) (← links)
- Modification of Sample Size in Group Sequential Clinical Trials (Q4666658) (← links)
- Statistical Issues On Objective, Design, And Analysis Of Noninferiority Active-controlled Clinical Trial (Q4796203) (← links)
- On some statistical methods for analysis of combination drug studies<sup>∗</sup> (Q4843734) (← links)
- Panel forum on multiple comparison procedures: A commentary from a complex trial design and analysis plan (Q4921947) (← links)
- Multiple comparisons in complex clinical trial designs (Q4921957) (← links)
- Utilities of the <i>P</i>‐value Distribution Associated with Effect Size in Clinical Trials (Q5122398) (← links)
- A Regulatory Perspective on Choice of Margin and Statistical Inference Issue in Non‐inferiority Trials (Q5122587) (← links)
- Discussion on “Establishing Efficacy of a New Experimental Treatment in the ‘Gold Standard’ Design” (Q5122771) (← links)
- Challenges and regulatory experiences with non‐inferiority trial design without placebo arm (Q5123178) (← links)
- Adaptive patient enrichment designs in therapeutic trials (Q5123181) (← links)
- Testing for the Existence of a Desirable Dose Combination (Q5286903) (← links)